Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype

Neuro Oncol. 2020 Dec 18;22(12):1894. doi: 10.1093/neuonc/noaa166.
No abstract available

Publication types

  • Published Erratum